Welcome to LookChem.com Sign In|Join Free

CAS

  • or
sodium 4-hydroxy-2-methylbenzenesulfonate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

132281-59-5 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 132281-59-5 Structure
  • Basic information

    1. Product Name: sodium 4-hydroxy-2-methylbenzenesulfonate
    2. Synonyms: sodium 4-hydroxy-2-methylbenzenesulfonate
    3. CAS NO:132281-59-5
    4. Molecular Formula:
    5. Molecular Weight: 210.186
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 132281-59-5.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: N/A
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: sodium 4-hydroxy-2-methylbenzenesulfonate(CAS DataBase Reference)
    10. NIST Chemistry Reference: sodium 4-hydroxy-2-methylbenzenesulfonate(132281-59-5)
    11. EPA Substance Registry System: sodium 4-hydroxy-2-methylbenzenesulfonate(132281-59-5)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 132281-59-5(Hazardous Substances Data)

132281-59-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 132281-59-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,2,2,8 and 1 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 132281-59:
(8*1)+(7*3)+(6*2)+(5*2)+(4*8)+(3*1)+(2*5)+(1*9)=105
105 % 10 = 5
So 132281-59-5 is a valid CAS Registry Number.

132281-59-5Upstream product

132281-59-5Downstream Products

132281-59-5Relevant articles and documents

Discovery and process development of a novel TACE inhibitor for the topical treatment of psoriasis

Boiteau, Jean-Guy,Ouvry, Gilles,Arlabosse, Jean-Marie,Astri, Stéphanie,Beillard, Audrey,Bhurruth-Alcor, Yushma,Bonnary, Laetitia,Bouix-Peter, Claire,Bouquet, Karine,Bourotte, Marilyne,Cardinaud, Isabelle,Comino, Catherine,Deprez, Beno?t,Duvert, Denis,Féret, Angélique,Hacini-Rachinel, Feriel,Harris, Craig S.,Luzy, Anne-Pascale,Mathieu, Arnaud,Millois, Corinne,Orsini, Nicolas,Pascau, Jonathan,Pinto, Artur,Piwnica, David,Polge, Ga?lle,Reitz, Arnaud,Reversé, Kevin,Rodeville, Nicolas,Rossio, Patricia,Spiesse, Delphine,Tabet, Samuel,Taquet, Nathalie,Tomas, Lo?c,Vial, Emmanuel,Hennequin, Laurent F.

, p. 945 - 956 (2018)

Targeting the TNFα pathway is a validated approach to the treatment of psoriasis. In this pathway, TACE stands out as a druggable target and has been the focus of in-house research programs. In this article, we present the discovery of clinical candidate

Nuclear Magnetic Resonance Studies of Complexes of Aluminium(III), Gallium(III), and Indium(III) with Disulphonated 2,2'-Dihydroxyazobenzene Ligands in Aqueous Solution

Evans, Dennis F.,Iki, Nobuhiko

, p. 3773 - 3779 (2007/10/02)

Proton n.m.r. spectra are reported for complexes of AlIII, GaIII, and InIII with a variety of 5,5'-disulphonated 2,2'-dihydroxyazobenzenes in D2O solution.Ligand exchange is slow on an n.m.r. time-scale, and both 1:1 and 1

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 132281-59-5